Similarities between Drospirenone and Postmenopausal hormone therapy
Drospirenone and Postmenopausal hormone therapy have 15 things in common (in Unionpedia): Acne, Birth control, Endometrium, Estradiol (medication), Estrogen, Estrogen (medication), Ethinylestradiol, Food and Drug Administration, Levonorgestrel, Liver disease, Menopause, Progesterone, Progestin, Progestogen, Venous thrombosis.
Acne
Acne, also known as acne vulgaris, is a long-term skin disease that occurs when hair follicles are clogged with dead skin cells and oil from the skin.
Acne and Drospirenone · Acne and Postmenopausal hormone therapy ·
Birth control
Birth control, also known as contraception and fertility control, is a method or device used to prevent pregnancy.
Birth control and Drospirenone · Birth control and Postmenopausal hormone therapy ·
Endometrium
The endometrium is the inner epithelial layer, along with its mucous membrane, of the mammalian uterus.
Drospirenone and Endometrium · Endometrium and Postmenopausal hormone therapy ·
Estradiol (medication)
Estradiol, also spelled oestradiol, is a medication and naturally occurring steroid hormone.
Drospirenone and Estradiol (medication) · Estradiol (medication) and Postmenopausal hormone therapy ·
Estrogen
Estrogen, or oestrogen, is the primary female sex hormone.
Drospirenone and Estrogen · Estrogen and Postmenopausal hormone therapy ·
Estrogen (medication)
An estrogen is a type of medication which is used most commonly in hormonal birth control and menopausal hormone therapy.
Drospirenone and Estrogen (medication) · Estrogen (medication) and Postmenopausal hormone therapy ·
Ethinylestradiol
Ethinylestradiol (EE) is an estrogen medication which is used widely in birth control pills in combination with progestins.
Drospirenone and Ethinylestradiol · Ethinylestradiol and Postmenopausal hormone therapy ·
Food and Drug Administration
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
Drospirenone and Food and Drug Administration · Food and Drug Administration and Postmenopausal hormone therapy ·
Levonorgestrel
Levonorgestrel is a hormonal medication which is used in a number of birth control methods.
Drospirenone and Levonorgestrel · Levonorgestrel and Postmenopausal hormone therapy ·
Liver disease
Liver disease (also called hepatic disease) is a type of damage to or disease of the liver.
Drospirenone and Liver disease · Liver disease and Postmenopausal hormone therapy ·
Menopause
Menopause, also known as the climacteric, is the time in most women's lives when menstrual periods stop permanently, and they are no longer able to bear children.
Drospirenone and Menopause · Menopause and Postmenopausal hormone therapy ·
Progesterone
Progesterone (P4) is an endogenous steroid and progestogen sex hormone involved in the menstrual cycle, pregnancy, and embryogenesis of humans and other species.
Drospirenone and Progesterone · Postmenopausal hormone therapy and Progesterone ·
Progestin
A progestin is a type of medication which is used most commonly in hormonal birth control and menopausal hormone therapy.
Drospirenone and Progestin · Postmenopausal hormone therapy and Progestin ·
Progestogen
Progestogens, also sometimes spelled progestagens or gestagens, are a class of steroid hormones that bind to and activate the progesterone receptor (PR).
Drospirenone and Progestogen · Postmenopausal hormone therapy and Progestogen ·
Venous thrombosis
A venous thrombus is a blood clot (thrombus) that forms within a vein.
Drospirenone and Venous thrombosis · Postmenopausal hormone therapy and Venous thrombosis ·
The list above answers the following questions
- What Drospirenone and Postmenopausal hormone therapy have in common
- What are the similarities between Drospirenone and Postmenopausal hormone therapy
Drospirenone and Postmenopausal hormone therapy Comparison
Drospirenone has 82 relations, while Postmenopausal hormone therapy has 137. As they have in common 15, the Jaccard index is 6.85% = 15 / (82 + 137).
References
This article shows the relationship between Drospirenone and Postmenopausal hormone therapy. To access each article from which the information was extracted, please visit: